Page last updated: 2024-10-31

nefazodone and Diabetes Mellitus, Type 2

nefazodone has been researched along with Diabetes Mellitus, Type 2 in 2 studies

nefazodone: may be useful as an opiate adjunct

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research Excerpts

ExcerptRelevanceReference
"Nefazodone is a relatively potent inhibitor of CYP3A4, a hepatic isoenzyme thought to play a major role in the metabolic elimination of zopiclone."1.31Possible interaction of zopiclone and nefazodone. ( Alderman, CP; Condon, JT; Gebauer, MG; Gilbert, AL, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warnock, JK1
Biggs, F1
Alderman, CP1
Gebauer, MG1
Gilbert, AL1
Condon, JT1

Other Studies

2 other studies available for nefazodone and Diabetes Mellitus, Type 2

ArticleYear
Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
    The American journal of psychiatry, 1997, Volume: 154, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Blood Glucose; Depressive Disorder; Diabetes Mellitus, Typ

1997
Possible interaction of zopiclone and nefazodone.
    The Annals of pharmacotherapy, 2001, Volume: 35, Issue:11

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Depressive

2001